BBA
Baker Bros. Advisors Portfolio holdings
AUM
$10.3B
This Quarter Return
+18.89%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$26.5B
AUM Growth
+$26.5B
(+6.1%)
Cap. Flow
-$53.2M
Cap. Flow
% of AUM
-0.2%
Top 10 Holdings %
Top 10 Hldgs %
84.24%
Holding
134
New
14
Increased
16
Reduced
60
Closed
7
Top Buys
| 1 |
AbCellera Biologics
ABCL
|
$421M |
| 2 |
Kodiak Sciences
KOD
|
$224M |
| 3 |
NVTA
Invitae Corporation
NVTA
|
$159M |
| 4 |
Ultragenyx Pharmaceutical
RARE
|
$61.5M |
| 5 |
Aligos Therapeutics
ALGS
|
$44.5M |
Top Sells
| 1 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$422M |
| 2 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$410M |
| 3 |
Exact Sciences
EXAS
|
$188M |
| 4 |
IMMU
Immunomedics Inc
IMMU
|
$20.2M |
| 5 |
AMRN
Amarin Corp
AMRN
|
$19.7M |
Sector Composition
| 1 | Healthcare | 97.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SGEN
1
DELISTED
Seagen Inc. Common Stock
SGEN
| $8.28B | 31.19% | 47,269,424 | – | – |
|
|
ONC
2
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $3.02B | 11.36% | 11,668,897 -1,632,700 | -12% | -$422M |
|
3
Incyte
INCY
$16.5B
| $2.78B | 10.49% | 31,999,741 +343 | +0% | +$29.8K |
|
4
Acadia Pharmaceuticals
ACAD
$4.38B
| $2.24B | 8.44% | 41,904,586 | – | – |
|
|
5
Kodiak Sciences
KOD
$478M
| $2.04B | 7.68% | 13,879,952 +1,527,777 | +12% | +$224M |
|
|
ALXN
6
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $1.37B | 5.16% | 8,760,794 | – | – |
|
7
Prelude Therapeutics
PRLD
$68.5M
| $724M | 2.73% | 10,118,636 | – | – |
|
8
BioMarin Pharmaceuticals
BMRN
$11.2B
| $666M | 2.51% | 7,589,294 | – | – |
|
|
NVTA
9
DELISTED
Invitae Corporation
NVTA
| $654M | 2.47% | 15,649,182 +3,798,220 | +32% | +$159M |
|
10
Ascendis Pharma
ASND
$11.8B
| $590M | 2.22% | 3,540,270 | – | – |
|
|
11
AbCellera Biologics
ABCL
$1.25B
| $421M | 1.58% | +10,450,180 | New | +$421M |
|
|
MRTX
12
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $310M | 1.17% | 1,409,784 | – | – |
|
13
argenx
ARGX
$43.6B
| $300M | 1.13% | 1,019,557 | – | – |
|
|
IGMS
14
DELISTED
IGM Biosciences
IGMS
| $278M | 1.05% | 3,144,892 +446 | +0% | +$39.4K |
|
15
Madrigal Pharmaceuticals
MDGL
$9.76B
| $167M | 0.63% | 1,499,213 | – | – |
|
|
AMRN
16
Amarin Corp
AMRN
$311M
| $137M | 0.52% | 27,991,761 -4,027,106 | -13% | -$19.7M |
|
17
Heron Therapeutics
HRTX
$207M
| $127M | 0.48% | 5,994,704 | – | – |
|
18
Kymera Therapeutics
KYMR
$2.95B
| $121M | 0.46% | 1,959,211 | – | – |
|
|
ALLK
19
DELISTED
Allakos
ALLK
| $100M | 0.38% | 714,250 +15,781 | +2% | +$2.21M |
|
20
Cerus
CERS
$251M
| $94.9M | 0.36% | 13,713,195 | – | – |
|
21
BioCryst Pharmaceuticals
BCRX
$1.74B
| $94.6M | 0.36% | 12,695,818 | – | – |
|
22
Pacific Biosciences
PACB
$393M
| $83.1M | 0.31% | 3,201,972 -48,028 | -1% | -$1.25M |
|
23
Zymeworks
ZYME
$1.12B
| $80.7M | 0.3% | 1,708,472 | – | – |
|
24
Insmed
INSM
$28.8B
| $71.8M | 0.27% | 2,156,001 -116,711 | -5% | -$3.89M |
|
|
FMTX
25
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $70.7M | 0.27% | 2,024,876 +253,367 | +14% | +$8.84M |
|